Recruiting

Observational Study

Sponsor:

Abbott Diabetes Care

Code:

NCT06921902

Conditions

Pre Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

FreeStyle Libre 3

Study Details

Brief summary:

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Conditions

Pre Diabetes

Study ID

NCT06921902

Start date

Feb 28, 2025

Status verified date

Apr, 2026

Completion date

Dec, 2026

Anticipated

Primary completion date

Dec, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Subject must be at least 18 years of age.
  • Subject must be willing and able to provide written signed and dated informed consent.

Exclusion Criteria:

  • Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
  • Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
  • Subject is known to be pregnant at the time of enrollment.
  • Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
  • Subject is currently on any form of treatment indicated for the treatment of diabetes.
  • Subject is currently on any form of medication indicated for weight loss.

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Interventions

FreeStyle Libre 3

Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)

Primary outcome measure

  • Characterize the glycemic profiles of people with and without a prediabetes diagnosis. [ Time Frame: up to 50 days ]

Central Contacts and Locations

Central contacts

MOHAMED NADA, PhD

5107495416adc.clinical@abbott.com

Locations

Diabetes and Obesity Care

Recruiting

Bend, Oregon, United States, 97702

More Information

Sponsor

Abbott Diabetes Care

Last update posted

Apr 9, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Abbott Diabetes Care on 2026-04-09.